Tumor Markers and Their Diagnostic Significance in Ovarian CancerAlkis Matsas, Dimitrios Iliopoulos, Dimitrios Stefanoudakis et al.|Life|2023Cited by 78
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic CancerDimitrios Stefanoudakis, Konstantinos G. Toutouzas, Maximos Frountzas et al.|Current Issues in Molecular Biology|2024Cited by 78
The Potential Revolution of Cancer Treatment with CRISPR TechnologyDimitrios Stefanoudakis, Alexandra Drakaki, Nikhita Kathuria‐Prakash et al.|Cancers|2023Cited by 63
Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future DirectionsDimitrios Stefanoudakis, Panagiotis Christopoulos, Evaggelia Karopoulou et al.|Life|2024Cited by 25
VEGF inhibition in urothelial cancer: the past, present and futureSanaz N. Ghafouri, Alexandra Drakaki, Aaron Burkenroad et al.|World Journal of Urology|2020Cited by 19